Access cutting-edge non-cystic fibrosis bronchiectasis treatment through this clinical trial at a research site in Birmingham. Study-provided care at no cost to qualified participants.
Access non-cystic fibrosis bronchiectasis specialists in Birmingham at no cost
This study follows strict safety protocols and ethical guidelines
All study-related non-cystic fibrosis bronchiectasis treatment provided free
This study is a randomized, double-blind, placebo-controlled study designed to assess the efficacy and safety of ensifentrine inhalation suspension (3 mg) delivered twice daily via standard jet nebulizer over at least 24 weeks, compared to placebo, in subjects with non-cystic fibrosis bronchiectasis (NCFBE).
Sponsor: Verona Pharma plc
Check if you qualify for this non-cystic fibrosis bronchiectasis clinical trial in Birmingham, AL
If you're searching for non-cystic fibrosis bronchiectasis treatment options in Birmingham, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Birmingham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced non-cystic fibrosis bronchiectasis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.